KL-6-producing invasive thymoma.
暂无分享,去创建一个
M. Mori | S. Kakizaki | H. Tsukagoshi | J. Iwasaki | T. Kawata | T. Kasahara | Y. Shimizu | T. Mashimo | Takayuki Kasahara
[1] J. Lüttges,et al. The Mucin Profile of Noninvasive and Invasive Mucinous Cystic Neoplasms of the Pancreas , 2002, The American journal of surgical pathology.
[2] H. Matsuda,et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma , 2002, Cancer.
[3] A. Giatromanolaki,et al. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance , 2002, Histopathology.
[4] G. Stamp,et al. MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: correlation with prognosis. , 2002, Human pathology.
[5] A. Sonnenberg,et al. Episialin ( MUC 1 ) Overexpression Inhibits Integrin-mediated Cell Adhesion to Extracellular Matrix Components , 2002 .
[6] G. Graeber,et al. Current status of the diagnosis and treatment of thymoma. , 2000, Seminars in thoracic and cardiovascular surgery.
[7] P. Kenemans,et al. Human MUC1 Mucin: A Multifaceted Glycoprotein , 2000, The International journal of biological markers.
[8] D. Strollo,et al. Tumors of the thymus. , 1999, Journal of thoracic imaging.
[9] N. Kohno,et al. Immunoreactive MUC1 Expression at the Deepest Invasive Portion Correlates with Prognosis of Colorectal Cancer , 1998, Oncology.
[10] J. Wesseling,et al. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.
[11] A. Sonnenberg,et al. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components , 1995, The Journal of cell biology.
[12] W. Gilks,et al. Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysis , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[13] N. Kohno,et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. , 1989, Chest.
[14] N. Kohno,et al. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. , 1988, Japanese journal of clinical oncology.
[15] Y. Monden,et al. Follow‐up study of thymomas with special reference to their clinical stages , 1981, Cancer.